Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback